62 related articles for article (PubMed ID: 35912210)
1. Lung cancer burden and trends from 2000 to 2018 in China: Comparison between China and the United States.
Teng Y; Xia C; Cao M; Yang F; Yan X; He S; Cao M; Zhang S; Li Q; Tan N; Wang J; Chen W
Chin J Cancer Res; 2023 Dec; 35(6):618-626. PubMed ID: 38204441
[TBL] [Abstract][Full Text] [Related]
2. Histological type distribution and expression of nm23, VEGF, TOP2A and MUM-1 in peripheral T-cell and NK-cell lymphomas in Chinese: analysis of 313 cases.
Huang W; Ma W; Qiu T; Shan L; Zeng L; Guo L; Ying J; Lv N; Feng X
Int J Clin Exp Pathol; 2018; 11(10):5086-5093. PubMed ID: 31949586
[TBL] [Abstract][Full Text] [Related]
3. Gynaecological cancer incidence and mortality trends in a Brazilian State with medium human development index: A 22-year analysis.
da Silva BEB; de Lemos LMD; Moura AR; Ferrari YAC; Lima MS; Santos MO; Lima CA
Cancer Epidemiol; 2024 Feb; 88():102493. PubMed ID: 38056244
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological characteristics of neuroendocrine neoplasms in Beijing: a population-based retrospective study.
Chi Y; Liu S; Zhang J; Li H; Yang L; Zhang X; Li H; Li Q; Wang N; Lu M; Zhuo M
BMC Public Health; 2024 May; 24(1):1396. PubMed ID: 38789981
[TBL] [Abstract][Full Text] [Related]
5. International epidemiology of liver cancer: geographical distribution, secular trends and predicting the future.
Mohammadian M; Allah Bakeshei K; Mohammadian-Hafshejani A
J Prev Med Hyg; 2020 Jun; 61(2):E259-E289. PubMed ID: 32803012
[TBL] [Abstract][Full Text] [Related]
6. Trends in incidence and mortality of female breast cancer during transition in Central China.
Cheng Y; Yan Y; Gong J; Yang N; Nie S
Cancer Manag Res; 2018; 10():6247-6255. PubMed ID: 30538571
[TBL] [Abstract][Full Text] [Related]
7. Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades.
Yen EY; Singh DR; Singh RR
Rheumatology (Oxford); 2024 Feb; 63(2):466-471. PubMed ID: 37216898
[TBL] [Abstract][Full Text] [Related]
8. Trends in incidence, mortality and survival of testicular cancer patients in Belarus.
Rolevich A; Yaumenenka A; Borodin D; Semenov S; Artsiushkevich L; Polyakov S; Konoplia N; Krasny S
Cent European J Urol; 2019; 72(4):357-368. PubMed ID: 32015904
[TBL] [Abstract][Full Text] [Related]
9. Descriptive Epidemiology and Survival Rate of Osteosarcoma: The First National Population-Based Study in the Middle East (2008-2014).
Karimi A; Ebrahimpour A; Sadighi M; Chehrassan M; Biglari F; Jafari Kafiabadi M; Akbari ME; Azizmohammad Looha M
Arch Bone Jt Surg; 2023; 11(10):649-657. PubMed ID: 37873526
[TBL] [Abstract][Full Text] [Related]
10. Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma.
Yap DRY; Lim JQ; Huang D; Ong CK; Chan JY
Front Immunol; 2023; 14():1068662. PubMed ID: 36776886
[TBL] [Abstract][Full Text] [Related]
11. Controversies in the Front-Line Treatment of Systemic Peripheral T Cell Lymphomas.
Sorigue M; Kuittinen O
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612216
[TBL] [Abstract][Full Text] [Related]
12. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma.
Chang EWY; Tan YH; Chan JY
J Hematol Oncol; 2024 Jun; 17(1):38. PubMed ID: 38824603
[TBL] [Abstract][Full Text] [Related]
13. Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation.
Kim SJ; Jo JC; Yoon DH; Yang DH; Yoon SE; Lee GW; Kong JH; Park Y; Kang KW; Lee HS; Oh SY; Shin HJ; Lee WS; Choi YS; Jeong SH; Kim MK; Kang HJ; Yi JH; Lim SN; Yhim HY; Do YR; Yun HJ; Eom HS; Lee MH; Suh C; Kim WS
Front Oncol; 2023; 13():1230629. PubMed ID: 37675232
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study.
Liu S; Liu W; Li H; Yang L; Song Y; Zhang X; Cheng Y; Li Q; Li H; Wang N; Zhu J; Ji J
Front Oncol; 2022; 12():863269. PubMed ID: 35912210
[TBL] [Abstract][Full Text] [Related]
15. Incidence trends for common subtypes of T-cell lymphoma in Taiwan and the United States from 2008-2020.
Huang CI; Ker CY; Li HJ; Hsiao YT; Lin SF; Su YC
Int J Hematol; 2024 Jun; 119(6):728-735. PubMed ID: 38494548
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort.
de Pádua Covas Lage LA; Brito CV; Levy D; Culler HF; Freitas Couto SC; de Oliveira LBA; Nogueira Zerbini MC; Rocha V; Pereira J
Leuk Res; 2022 Mar; 114():106794. PubMed ID: 35131666
[TBL] [Abstract][Full Text] [Related]
17. Cancer awareness, diagnosis and treatment needs in Mizoram, India: evidence from 18 years trends (2003-2020).
Zomawia E; Zami Z; Vanlallawma A; Kumar NS; Zothanzama J; Tlau L; Chhakchhuak L; Pachuau L; Pautu JL; Hmangaihzuali EVL
Lancet Reg Health Southeast Asia; 2023 Oct; 17():100281. PubMed ID: 37780980
[TBL] [Abstract][Full Text] [Related]
18. Update on T-Cell Lymphoma Epidemiology.
Chen JJ; Tokumori FC; Del Guzzo C; Kim J; Ruan J
Curr Hematol Malig Rep; 2024 Jun; 19(3):93-103. PubMed ID: 38451372
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
